George A. Joulwan, Director at Emergent BioSolutions Inc. (EBS), sold 28,502 shares at $41.24 ($1.2M) on 2017-11-07, disclosed to the SEC on 2017-11-09.
Open-market sale of $1.2M EBS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.24 | 3,946 | $163K | 13.8% |
| 2 | $41.24 | 3,946 | $163K | 13.8% |
| 3 | $41.24 | 10,305 | $425K | 36.2% |
| 4 | $41.24 | 10,305 | $425K | 36.2% |
| Total | $41.24 avg | 28,502 | $1.2M | 100% |
| Filing → |
| EBS | SELL | 2018-11-08 | $556K | — | Filing → |
| EBS | SELL | 2018-06-12 | $264K | — | Filing → |
| EBS | SELL | 2016-06-07 | $207K | — | Filing → |